XNAS
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2024-08-14 | H1 2024 | — | 0.01 | — | $12.6M | — | +0.00% | +3.54% | +14.69% |
| 2023-08-04 | H1 2023 | — | 0.05 | — | $29.2M | — | — | — | — |
| 2023-04-19 | FY 2022 |
| — |
| 0.15 |
| — |
| $64.9M |
| — |
| — |
| — |
| — |
Showing last 3 quarters.